Concepedia

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

Christopher B. Granger, John J.V. McMurray, Salim Yusuf, Peter Held, Eric L. Michelson, Bertil Olofsson, Jan Östergren, Marc A. Pfeffer, Karl Swedberg

The Lancet · 2003 · 1.7K citations · 17 references

DOI

Concepts

References

17

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

New England Journal of Medicine · 1991 · 8.1K citations · Full text

, , +12

A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure

Jay N. Cohn, Gianni Tognoni · New England Journal of Medicine · 2001 · 3.1K citations · Full text

, , +13

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

Marc A. Pfeffer, Karl Swedberg, Christopher B. Granger et al. · The Lancet · 2003 · 1.9K citations

, , +11

The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe Part 1: patient characteristics and diagnosis

John G.F. Cleland · European Heart Journal · 2003 · 1.5K citations · Full text

, , +16

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials

R. Garg · JAMA · 1995 · 1.5K citations

, , +16